This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: University System of Maryland, Research Corporation Technologies, Inc.. Active years: 1986-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Baltimore, MD (US) (1986 - 1995)
- Timonium, MD (US) (1999)
Company Filing History:


Years Active: 1986-1999
Title: Enrico Bucci: Innovator in Hemoglobin Research
Introduction
Enrico Bucci is a notable inventor based in Baltimore, MD (US), recognized for his contributions to the field of hemoglobin research. He holds a total of 5 patents, showcasing his innovative approach to developing physiologically competent oxygen carriers.
Latest Patents
Bucci's latest patents include significant advancements in hemoglobin technology. One of his patents describes polymerized hemoglobin, which is intermolecularly cross-linked to transform stroma-free hemoglobin into a competent oxygen carrier. This innovation allows for the retention of hemoglobin in vivo for adequate periods, making it suitable for use in fluids that transport oxygen. Another patent focuses on hemoglobin that is intramolecularly cross-linked with long-chain divalent reagents. This method mimics 2,3-diphosphoglycerate, enhancing the physiological competence of stroma-free hemoglobin for effective oxygen transport.
Career Highlights
Throughout his career, Enrico Bucci has worked with esteemed organizations such as the University System of Maryland and Research Corporation Technologies, Inc. His work has significantly impacted the field of medical research, particularly in the development of oxygen-carrying solutions.
Collaborations
Bucci has collaborated with notable colleagues, including Clara Fronticelli and William Brinigar, contributing to the advancement of hemoglobin research through teamwork and shared expertise.
Conclusion
Enrico Bucci's innovative work in hemoglobin research has led to important advancements in medical technology. His patents reflect a commitment to improving oxygen transport solutions, which can have significant implications for healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile